Introduction The scope of oncology has changed greatly over the past decade as therapies for cancer have moved toward creating or intensifying an immune response against it. The ever-growing number of therapies uses a multitude of different mechanisms, including blockade…
Drugs covered 1. Nonsteroidal antiinflammatory drugs (NSAIDs) 2. Angiotensin-converting enzyme (ACE) and angiotensin-receptor blocker (ARB) 3. Sodium phosphate 4. Pamidronate and zoledronate 5. Proton pump inhibitors (PPIs) 6. Checkpoint inhibitors (CPI) chemotherapy 7. Antiangiogenesis drugs 8. Cisplatin 9. Braf inhibitors…
Primary interstitial kidney disease comprises a diverse group of disorders that elicit interstitial inflammation associated with tubular damage. Traditionally, interstitial nephritis has been classified morphologically and clinically into acute and chronic forms. Acute interstitial nephritis (AIN) generally induces rapid deterioration…
Medications are an essential intervention to provide appropriate patient care, and new agents are being introduced into clinical practice at a rapid pace. Although most drugs are well tolerated, kidney injury remains an unfortunate and relatively frequent adverse consequence. Some…